In various cancer cell lines, the expression of B3GNT5 was evaluated, revealing that the HNSC, ESCA, small cell lung cancer (SCLC), and PAAD cell lines exhibited the highest levels of B3GNT5 expression (Fig 1D). Here, B3GNT5 is linked to small cell lung carcinoma.